Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Although prescribing information (PI) is often the initial source of information when identifying potential drug-drug interactions, it may only provide a limited number of exemplars or only reference a class of medications without providing any specific medication examples. In the case of medical ca...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2020-07-01
|
| Series: | Medical Cannabis and Cannabinoids |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/507998 |